UCB Pharma GmbH
Schwarz Pharma AG:Changes within the Executive Board of SCHWARZ PHARMA AG
SCHWARZ PHARMA AG / Change of Personnel Release of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- Changes within the Executive Board of SCHWARZ PHARMA AG Today the Supervisory Board of SCHWARZ PHARMA announced that Detlef Thielgen, Chief Executive Officer (CEO) and Executive Board Member will resign as of 31. October 2007, in order to focus on his function as Chief Financial Officer (CFO) of UCB S.A. in Brussels. The Supervisory Board appointed Peter Möller to new Chief Executive Officer of SCHWARZ PHARMA AG as of 1. November 2007. As of January 1, 2007 Peter Möller has been appointed to Executive Board Member of SCHWARZ PHARMA AG and is responsible for legal affairs. Since November 1997 he is working for SCHWARZ PHARMA. He is a lawyer and during the first seven years at SCHWARZ PHARMA he worked in leading positions in different areas of the legal department. Since 2005 he is responsible for Corporate Counsel of SCHWARZ PHARMA AG. Furthermore the Supervisory Board of SCHWARZ PHARMA AG appointed Simon Looman to new Executive Board Member effective from January 1, 2008 on. Since 1983 Simon Looman is working for UCB in a variety of capacities and several countries. Since 2000 he is responsible for UCB SA Brussels as President for the European business. In his new function he will be Chief Operating Officer. You find more information on the internet: www.schwarzpharma.com SCHWARZ PHARMA AG is listed in the General Standard of the Frankfurter Wertpapierbörse (Frankfurt stock exchange). Security code no. 722 190 / ISIN no.: DE 0007221905 SCHWARZ PHARMA AG Alfred-Nobel-Str. 10 40789 Monheim Germany Corporate Communications: Sylvia Heitzer, Tel: +49 2173 48 1238 Contact: Corporate Communications: Sylvia Heitzer, Tel: +49 2173 48 1238; 22.10.2007 Financial News transmitted by DGAP ---------------------------------------------------------------------- Language: English Issuer: SCHWARZ PHARMA AG Alfred-Nobel-Str. 10 40789 Monheim Deutschland Phone: +49 2173 48 1866 Fax: +49 2173 48 1856 E-mail: antje.witte@schwarzpharma.com Internet: www.schwarzpharma.com ISIN: DE0007221905 WKN: 722190 Listed: Amtlicher Markt in Frankfurt (General Standard), Düsseldorf; Freiverkehr in Berlin, Hannover, München, Hamburg, Stuttgart End of News DGAP News-Service ---------------------------------------------------------------------------
Latest News
Latest Reports
Upcoming Events
No Events found
Webcasts
No Webcasts found